Arend Named New Co-Leader of Experimental Therapeutics Progr

The O’Neal Comprehensive Cancer Center at UAB is pleased to announce that Rebecca Arend, M.D., MSPH, will join Drs. Narendra Wajapeyee and Suzanne Lapi as Co-Leader of the O’Neal Experimental Therapeutics Research Program.

Related Keywords

Narendra Wajapeyee , Rebecca Arend , Trophoblastic Neoplasia , Data Safety Monitoring Committee , Department Of Obstetrics , Heersink School Of Medicine , Albert Einstein College Of Medicine , Oneal Comprehensive Cancer Center , Division Of Gynecologic Oncology , Gynecologic Oncology Working Group , Oneal Experimental Therapeutics Research Program , Society Of Gynecologic Oncology , Suzanne Lapi As Co , O Neal Comprehensive Cancer Center , Suzanne Lapi , O Neal Experimental Therapeutics Research , Gynecologic Oncology , Albert Einstein College , Columbia Presbyterian Hospital , Public Heath , O Neal Comprehensive Cancer , Endometrial Cancer , Cervical Cancer , Vulvar Cancer , Gestational Trophoblastic , Emerging Clinical Trialists Course , Experimental Therapeutics , O Neal Comprehensive Cancer Center At The University Of Alabama Birmingham , News , Press Release ,